Tomoko Matsuoka

1.2k citations
26 papers · 976 indexed · 1 hit paper · h-index 8
Topics
Antibiotic Use and Resistance (12 papers)Antibiotics Pharmacokinetics and Efficacy (5 papers)Pharmaceutical Practices and Patient Outcomes (5 papers)
Partner nations
Japan

In The Last Decade

Tomoko Matsuoka

21 papers receiving 926 citations

Hit Papers

Inhibition of.ALPHA.-Glucosidase and.ALPHA.-Amylase by Fl...20062026201220192006250500750

Peers

Tomoko Matsuoka
Comparison fields: 5 of 87
  • Endocrinology, Diabetes and Metabolism 465
  • Biochemistry 402
  • Plant Science 216
  • Molecular Biology 185
  • Nutrition and Dietetics 169
Replace Sabine Kuntz with:
Sabine Kuntz Germany
Rajiv Gandhi Gopalsamy Brazil
Shi Sun United States
J.M.M. van Amelsvoort Netherlands
Mariam Ahmad Malaysia
Jakub P. Piwowarski Poland
Asimina Kerimi United Kingdom
Enrica Bosisio Italy
Fatma Ergün Türkiye
Karin Struijs Belgium
Tomoko Matsuoka relative to Sabine Kuntz Germany Sabine Kuntz's profile →
Citations per field
00.5×3.8×
Sabine Kuntz · 1×
Citations per year

Countries citing papers authored by Tomoko Matsuoka

Since Specialization
Citations

This map shows the geographic impact of Tomoko Matsuoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Matsuoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Matsuoka more than expected).

Fields of papers citing papers by Tomoko Matsuoka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Matsuoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Matsuoka. The network helps show where Tomoko Matsuoka may publish in the future.

Co-authorship network of co-authors of Tomoko Matsuoka

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Matsuoka. A scholar is included among the top collaborators of Tomoko Matsuoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Matsuoka. Tomoko Matsuoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 4
4 1
5 1
6 0
7 3
8 12
9 4
10 4
11 21
12 7
13 2
14 19
15
[Continuation of chemotherapy with bevacizumab for advanced and recurrent colorectal cancer].
0
16
[Appearance of skin and nail toxicity in patients with breast cancer who underwent trastuzumab-containing chemotherapy].
8
17
[Clinical evaluation of calculating carboplatin doses using modification of diet in renal disease (MDRD) estimate and adverse events].
2
18
Inhibition of .ALPHA.-Glucosidase and .ALPHA.-Amylase by Flavonoidsbreakdown →
854
19 3
20 15

About Tomoko Matsuoka

Tomoko Matsuoka is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology and Clinical Biochemistry, having authored 26 papers that have together received 976 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (12 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). The work is most often cited by research in Biochemistry (402 citations), Endocrinology, Diabetes and Metabolism (465 citations) and Applied Microbiology and Biotechnology (54 citations). Tomoko Matsuoka has collaborated with scholars based in Japan. Frequent co-authors include Kenjiro Tadera, Yuji Minami, Tomoaki Yoshimura, Tadashi Sugiyama, Takayuki Mōri, Shinya Yoshida, Hirokuni Taguchi, Tetsuya Yagi, Yasuyuki Fukami and Joe Shindoh. Their work appears in journals such as Biological and Pharmaceutical Bulletin, American Journal of Hematology and American Journal of Infection Control.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026